Amy O'donnell

Amy O’Donnell, J.D., M.D., is a neurologist who joined Biohaven as Vice President, Head of Pharmacovigilance after 18 years in the pharmaceutical industry. Amy spent the last 6 years at Janssen where she led the Safety Management Team for two Neuroscience drugs and served as medical lead for a medical affairs post-marketing study.

Prior to that, she spent 7 years at Inventiv Health, where she served as medical monitor for studies in a variety of Neuroscience indications including pain, multiple sclerosis, autism, Parkinson’s disease and schizophrenia. Amy spent the early part of her career at Bristol-Myers Squibb in drug safety and Neuroscience clinical development. Amy received her MD from Brown University Medical School. After finishing her Neurology residency at Brown, she completed a fellowship in Headache Disorders at Harvard. She also has a law degree from New York University Law School and a B.A. from Bryn Mawr College.